774 related articles for article (PubMed ID: 9171934)
61. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
Pericle F; Giovarelli M; Colombo MP; Ferrari G; Musiani P; Modesti A; Cavallo F; Di Pierro F; Novelli F; Forni G
J Immunol; 1994 Dec; 153(12):5659-73. PubMed ID: 7989764
[TBL] [Abstract][Full Text] [Related]
62. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
Frey AB
J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
[TBL] [Abstract][Full Text] [Related]
63. Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy.
Li B; VanRoey MJ; Jooss K
Clin Immunol; 2007 May; 123(2):155-65. PubMed ID: 17320482
[TBL] [Abstract][Full Text] [Related]
64. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
Townsend SE; Su FW; Atherton JM; Allison JP
Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
[TBL] [Abstract][Full Text] [Related]
65. [The anti-tumor activity of GM-CSF-modified lung cancer cell vaccine and its synergism in combination with chemotherapy].
Jiang HJ; Ren XB; Li H; Yu JP; Wei F; Ma MQ
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):808-12. PubMed ID: 18396635
[TBL] [Abstract][Full Text] [Related]
66. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
[TBL] [Abstract][Full Text] [Related]
67. Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes.
Arca MJ; Krauss JC; Strome SE; Cameron MJ; Chang AE
Cancer Immunol Immunother; 1996 May; 42(4):237-45. PubMed ID: 8665571
[TBL] [Abstract][Full Text] [Related]
68. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO
Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173
[TBL] [Abstract][Full Text] [Related]
69. Protective immunity induced by B7/CD28-costimulated gamma delta T cells to the EL-4 lymphoma in allogenic athymic mice.
Li Y; Newby SA; Johnston JV; Hellström KE; Chen L
J Immunol; 1995 Dec; 155(12):5705-10. PubMed ID: 7499857
[TBL] [Abstract][Full Text] [Related]
70. Dissociated expression of granulocyte-macrophage CSF and IL-3 in short-term T cell clones from normal mice.
Fitzpatrick DR; Kelso A
J Immunol; 1995 Dec; 155(11):5140-50. PubMed ID: 7594523
[TBL] [Abstract][Full Text] [Related]
71. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
Giovarelli M; Musiani P; Modesti A; Dellabona P; Casorati G; Allione A; Consalvo M; Cavallo F; di Pierro F; De Giovanni C
J Immunol; 1995 Sep; 155(6):3112-23. PubMed ID: 7673726
[TBL] [Abstract][Full Text] [Related]
72. The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT).
Harada M; Matsunaga K; Oguchi Y; Iijima H; Ito O; Tamada K; Kimura G; Nomoto K
Cancer Res; 1995 Dec; 55(24):6146-51. PubMed ID: 8521406
[TBL] [Abstract][Full Text] [Related]
73. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism.
Pulaski BA; McAdam AJ; Hutter EK; Biggar S; Lord EM; Frelinger JG
Cancer Res; 1993 May; 53(9):2112-7. PubMed ID: 8097675
[TBL] [Abstract][Full Text] [Related]
74. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
[TBL] [Abstract][Full Text] [Related]
75. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
[TBL] [Abstract][Full Text] [Related]
76. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
[TBL] [Abstract][Full Text] [Related]
77. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
78. Adoptive transfer of murine cytomegalovirus-immune lymph node cells prevents retinitis in T-cell-depleted mice.
Lu Y; Bigger JE; Thomas CA; Atherton SS
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):301-10. PubMed ID: 9040462
[TBL] [Abstract][Full Text] [Related]
79. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
[TBL] [Abstract][Full Text] [Related]
80. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]